Stocktoria
iRhythm Holdings, Inc. IRTC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-10-20
iRhythm Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M |
| Gross profit | $527.2M | $407.5M | $331.8M | $281.6M | $213.6M |
| R&D expense | — | — | $60.2M | $46.6M | $38.7M |
| SG&A expense | $492.6M | $418.6M | $385.6M | $322.2M | $274.8M |
| Operating income | -$57.4M | -$115.5M | -$125.2M | -$113.8M | -$99.9M |
| Interest expense | — | — | $3.6M | $4.1M | $1.2M |
| Income tax | $953,000 | $565,000 | $750,000 | $269,000 | $367,000 |
| Net income | -$44.6M | -$113.3M | -$123.4M | -$116.2M | -$101.4M |
| EPS (diluted) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| Operating cash flow | $80.9M | $3.4M | -$50.1M | -$23.0M | -$37.8M |
| Free cash flow | $34.5M | -$30.6M | -$90.5M | -$52.8M | -$65.8M |
| Cash & equivalents | $236.0M | $419.6M | $36.2M | $78.8M | $127.6M |
| Inventory | $21.6M | $14.0M | $14.0M | $15.2M | $10.3M |
| Total assets | $1.0B | $931.4M | $433.1M | $448.2M | $463.0M |
| Total liabilities | $867.3M | $840.5M | $223.0M | $208.4M | $183.5M |
| Shareholders' equity | $152.7M | $90.9M | $210.1M | $239.8M | $279.5M |
Source: SEC EDGAR filings · CIK 0001388658 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.